Back
ESC Premium Access

Questions and answers

Session: Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?
Topic: Diabetes and the Heart
Sponsored by MSD
Event: ESC CONGRESS 2019

Congress Presentation

0

6 more presentations in this session

Welcome and opening remarks

Speaker: Professor D. McGuire (Dallas, US)

Access
Slides
Video
0
Thumbnail

What is the role for SGLT2is for patients with heart failure? A cardiologist’s view

Speaker: Professor G. Filippatos (Athens, GR)

Access
Slides
Video
0
Thumbnail

SGLT2 Inhibitors - Diabetes or renal drugs?

Speaker: Professor P. Groop (Helsinki, FI)

Access
Slides
Video
0
Thumbnail

Ertugliflozin and the VERTIS program – What have we learned to date?

Speaker: Professor L. Leiter (Toronto, CA)

Access
Slides
Video
0
Thumbnail

Bringing forward the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease - A roundtable dscussion

Speaker: Professor D. McGuire (Dallas, US) Professor L. Leiter (Toronto, CA) Professor G. Filippatos (Athens, GR) Professor P. Groop (Helsinki, FI)

Access
0
Thumbnail

Access the full session

Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

Speakers: Professor D. McGuire, Professor G. Filippatos, Professor P. Groop, Professor L. Leiter, Professor D. McGuire...
Access
0
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk